Illumina Inc

Затворен

СекторЗдравеопазване

187.48 2.12

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

186.69

Максимум

188.79

Ключови измерители

By Trading Economics

Приходи

-200M

134M

Продажби

-68M

1.1B

P/E

Средно за сектора

32.042

56.269

EPS

1.15

Марж на печалбата

12.282

Служители

8,600

EBITDA

-219M

226M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

-17.66% downside

Дивиденти

By Acuity

Следващи печалби

30.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

7.2B

27B

Предишно отваряне

185.36

Предишно затваряне

187.48

Настроения в новините

By Acuity

21%

79%

46 / 342 Класиране в Healthcare

Illumina Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.07.2026 г., 23:06 ч. UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader trends despite positive movements in European equity indices, including a rise in the DAX.

1.07.2026 г., 20:03 ч. UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

30.06.2026 г., 20:01 ч. UTC

News
Social Media

Illumina Inc shares are lower as Roche launches a competing gene sequencer at a lower price, challenging Illumina's market share in genetic testing technology.

29.06.2026 г., 23:16 ч. UTC

Illumina Inc shares are lower in after-market trading, with no specific news identified to explain the movement. Broader U.S. equities show mixed performance.

26.06.2026 г., 23:16 ч. UTC

Illumina Inc shares are trading lower in after-market hours. Broader market concerns over rising interest rates and inflation may be influencing investor behavior.

25.06.2026 г., 23:26 ч. UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

24.06.2026 г., 20:02 ч. UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23.06.2026 г., 22:46 ч. UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22.06.2026 г., 19:32 ч. UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19.06.2026 г., 00:02 ч. UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18.06.2026 г., 23:01 ч. UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17.06.2026 г., 20:03 ч. UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16.06.2026 г., 19:56 ч. UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15.06.2026 г., 13:02 ч. UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12.06.2026 г., 19:56 ч. UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11.06.2026 г., 20:03 ч. UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10.06.2026 г., 23:11 ч. UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9.06.2026 г., 19:26 ч. UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8.06.2026 г., 20:06 ч. UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5.06.2026 г., 23:16 ч. UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4.06.2026 г., 19:51 ч. UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3.06.2026 г., 23:03 ч. UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2.06.2026 г., 23:21 ч. UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1.06.2026 г., 23:46 ч. UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29.05.2026 г., 20:03 ч. UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28.05.2026 г., 23:26 ч. UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27.05.2026 г., 20:02 ч. UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21.05.2026 г., 19:42 ч. UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20.05.2026 г., 19:56 ч. UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

Сравнение с други в отрасъла

Ценова промяна

Illumina Inc Прогноза

Ценова цел

By TipRanks

-17.66% надолу

12-месечна прогноза

Среден 155.36 USD  -17.66%

Висок 200 USD

Нисък 95 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за Illumina Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

14 ratings

7

Купи

4

Задържане

3

Продай

Настроение

By Acuity

46 / 342 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat